Neville Rodie & Shaw’s NVIDIA NVDA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$25M Sell
124,777
-4,570
-4% -$940K 1.62% 15
2026
Q1
$22.6M Buy
129,347
+106
+0.1% +$19.4K 1.64% 16
2025
Q4
$24.1M Buy
129,241
+2,234
+2% +$416K 1.7% 15
2025
Q3
$23.7M Sell
127,007
-10,167
-7% -$1.77M 1.71% 15
2025
Q2
$21.7M Buy
137,174
+16,200
+13% +$2.04M 1.61% 18
2025
Q1
$13.1M Buy
120,974
+549
+0.5% +$69.6K 1.03% 28
2024
Q4
$16.2M Buy
120,425
+1,819
+2% +$251K 1.18% 23
2024
Q3
$14.4M Sell
118,606
-7,999
-6% -$945K 1.06% 26
2024
Q2
$15.6M Sell
126,605
-5,695
-4% -$576K 1.19% 23
2024
Q1
$12M Buy
132,300
+42,030
+47% +$3.05M 0.91% 31
2023
Q4
$4.47M Buy
90,270
+74,470
+471% +$3.45M 0.37% 60
2023
Q3
$687K Hold
15,800
0.06% 145
2023
Q2
$668K Sell
15,800
-2,500
-14% -$83K 0.06% 151
2023
Q1
$508K Hold
18,300
0.05% 178
2022
Q4
$267K Sell
18,300
-9,000
-33% -$132K 0.03% 223
2022
Q3
$331K Buy
27,300
+9,000
+49% +$142K 0.03% 207
2022
Q2
$277K Hold
18,300
0.02% 221
2022
Q1
$489K Hold
18,300
0.04% 191
2021
Q4
$538K Buy
+18,300
New +$504K 0.04% 189

Other funds holding NVDA

Neville Rodie & Shaw's NVDA Position: Q2 2026 in Review

Neville Rodie & Shaw reduced its NVIDIA (NVDA) stake by 3.5% in Q2 2026, selling an estimated $940K and leaving 124,777 shares worth $25M. The position accounts for 1.62% of the portfolio, ranked #15.

Neville Rodie & Shaw first reported a position in NVDA in Q4 2021 and has held it in 19 quarters since. 2,020 funds tracked by Wall St. Rank hold NVDA as of Q2 2026.

  • Neville Rodie & Shaw held 124,777 shares of NVIDIA worth $25M as of Q2 2026.
  • Neville Rodie & Shaw sold 4,570 NVIDIA shares in Q2 2026, an estimated $940K.
  • NVIDIA made up 1.62% of Neville Rodie & Shaw's portfolio in Q2 2026, its #15 holding.
  • Neville Rodie & Shaw first reported a position in NVIDIA in Q4 2021 and has held it in 19 quarters since.
  • 2,020 funds tracked by Wall St. Rank held NVIDIA as of Q2 2026.

Based on Neville Rodie & Shaw's 13F filing for Q2 2026, filed 6 Jul 2026.